Bacterial co‐infections with SARS‐CoV‐2
Open Access
- 8 August 2020
- journal article
- review article
- Published by Wiley in IUBMB Life
- Vol. 72 (10), 2097-2111
- https://doi.org/10.1002/iub.2356
Abstract
The pandemic coronavirus disease 2019 (COVID‐19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), has affected millions of people worldwide. To date, there are no proven effective therapies for this virus. Efforts made to develop antiviral strategies for the treatment of COVID‐19 are underway. Respiratory viral infections, such as influenza, predispose patients to co‐infections and these lead to increased disease severity and mortality. Numerous types of antibiotics such as azithromycin have been employed for the prevention and treatment of bacterial co‐infection and secondary bacterial infections in patients with a viral respiratory infection (e.g., SARS‐CoV‐2). Although antibiotics do not directly affect SARS‐CoV‐2, viral respiratory infections often result in bacterial pneumonia. It is possible that some patients die from bacterial co‐infection rather than virus itself. To date, a considerable number of bacterial strains have been resistant to various antibiotics such as azithromycin, and the overuse could render those or other antibiotics even less effective. Therefore, bacterial co‐infection and secondary bacterial infection are considered critical risk factors for the severity and mortality rates of COVID‐19. Also, the antibiotic‐resistant as a result of overusing must be considered. In this review, we will summarize the bacterial co‐infection and secondary bacterial infection in some featured respiratory viral infections, especially COVID‐19.Keywords
This publication has 165 references indexed in Scilit:
- Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States*Critical Care Medicine, 2012
- Regulating the adaptive immune response to respiratory virus infectionNature Reviews Immunology, 2012
- Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cellsJournal of General Virology, 2011
- Influenza Virus Primes Mice for Pneumonia From Staphylococcus aureusThe Journal of Infectious Diseases, 2011
- Respiratory syncytial virus-induced dysregulation of expression of a mucosal β-defensin augments colonization of the upper airway by non-typeableHaemophilus influenzaeCellular Microbiology, 2009
- Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza PreparednessThe Journal of Infectious Diseases, 2008
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?Epidemiology and Infection, 2008
- Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome CoronavirusOnline Journal of Public Health Informatics, 2007
- Insights into the Interaction between Influenza Virus and PneumococcusClinical Microbiology Reviews, 2006